AngioDynamics | ANGO - Selling And Administration Expenses


AngioDynamics reported $35.99M in Selling and Administration Expenses for its fiscal quarter ending in February of 2025.





Selling And Administration Expenses Change Date
AngioDynamics USD 35.99M 14K Feb/2025
AtriCure USD 78.23M 158K Sep/2025
Boston Scientific USD 1.83B 93M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
ICU Medical USD 152.77M 6.62M Sep/2025
Inogen USD 43.77M 510K Jun/2024
J&J USD 6.75B 831M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Mesa Laboratories USD 27.31M 380K Sep/2024
Orthofix International USD 112.21M 1.1M Sep/2024
Smiths GBP 328M 12M Dec/2025
Surmodics USD 14.58M 2.05M Sep/2024
Tandem Diabetes Care USD 94.52M 1.47M Sep/2025
Teleflex USD 281.76M 66.68M Sep/2025
Terumo JPY 97.88B 5.9B Sep/2025
Trinity Biotech USD 6.19M 2.18M Sep/2025